All In Biotech

Drug Trial Radar · NCT06266767

Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour Analgesia

Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour Analgesia; Finding the Optimum Combination

Last checked: Nov 20, 2026Latest source record: Nov 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 136 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

136

Actual

Start

Feb 21, 2024

Primary completion

Oct 5, 2024

Study completion Oct 5, 2024

Sponsor

Lead sponsor
Hamad Medical CorporationIndustry
Sponsor type
Industry
First posted
Feb 20, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Sequential
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Health services research
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Epidural Analgesia remains the most effective form of pain relief in labour. After initiating epidural analgesia, there are many epidural drug regimens that can be employed to maintain analgesia for the duration of labour using an epidural catheter. Due to recent advances in medical technology, new epidural pumps, which allow both patient controlled epidural analgesia boluses (PCEA, a common standard of care in many hospitals) and programmed intermittent epidural boluses (PIEB, automatic boluses given in addition to the PCEA bolus), are now available. In this randomized double-blind trial, we aim to evaluate the effects of different combinations of PIEB (epidural bolus volume) and PIEB (bolus volume and time interval) on labour patient-controlled epidural analgesia (PCEA) usage. In theory, the more effective the PIEB combination (the ideal drug volume and ideal time interval), the less PCEA boluses (extra epidural drug) will be used as well as less clinician boluses and less lower limb weakness (motor block) as assessed by the Bromage Score.

Conditions

  • Labor Pain
  • Obstetric Pain
  • Analgesia

Interventions

  • Levobupivacaine and FentanylDrug

    Programmed Intermittent Epidural Bolus

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The volume of local anaesthetic mixture for breakthrough pain (PCEA + clinician bolus) + the Bromage ScoreTime frame: From the siting of the epidural block to the delivery of the fetus (maximum 24 hrs)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hamad Medical Corporation (HMC)

    Doha, Baladiyat ad Dawhah, Qatar

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.